Loading...
Nordic Life Science 1
“3Z PHARMACEUTICAL’S PIPELINE CURRENTLY CONSISTS
OF FOUR PROJECTS IN DRUG DEVELOPMENT AND PRE-CLINICAL STAGES, TARGETING PARKINSON’S, SCHIZOPRENIA, ADHD AND EDS.”